Immunosuppresion: Clinical Trials

1 trial for Immunosuppresion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Immunosuppresion: new trials by email Literature Review of Immunosuppresion trials Research Report on Immunosuppresion

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Dexamethasone, Tocilizumab, Anakinra - Sepsis, Neuroinflammatory Response
Phase 4UnknownRadboud University Medical Center522024-10-242025-04-04

Narrower conditions

Endotoxemia (1)  ·  Neuroinflammatory Diseases (1)  ·  Sepsis (1)

Broader conditions

Bacteremia (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)  ·  Toxemia (1)

Interventions

Dexamethasone (1)  ·  Endotoxins (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Lipopolysaccharides (1)  ·  Sodium Chloride (1)  ·  tocilizumab (1)

Sponsors

Radboud University Medical Center (1)

Countries

Netherlands (1)

NIH funding

2023 (1)